Rituximab, Venetoclax, and Bortezomib for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Rutgers, The State University of New Jersey
Rutgers, The State University of New Jersey
Juventas Cell Therapy Ltd.
Fred Hutchinson Cancer Center
Zhujiang Hospital
Ludwig-Maximilians - University of Munich
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Children's Oncology Group
M.D. Anderson Cancer Center
Shanghai Pudong Hospital
Duke University
Roswell Park Cancer Institute
Second Affiliated Hospital of Xi'an Jiaotong University
Jonsson Comprehensive Cancer Center
University of California, San Francisco
University of Texas Southwestern Medical Center
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
The Methodist Hospital Research Institute
Celgene
Mayo Clinic
University of Alabama at Birmingham
AIDS Malignancy Consortium
Hoag Memorial Hospital Presbyterian
Fred Hutchinson Cancer Center
Children's Oncology Group
Mayo Clinic
Barbara Ann Karmanos Cancer Institute
M.D. Anderson Cancer Center
University of California, San Francisco
Roswell Park Cancer Institute
Enzon Pharmaceuticals, Inc.
M.D. Anderson Cancer Center